Latest Financial Stability News

Page 11 of 30
Atomo Diagnostics reported a 27% reduction in net loss to AUD 4.97 million for FY25, alongside a 7% revenue dip to AUD 3.79 million, driven by stronger margins and cost controls. The company also secured a significant US distribution contract through partner Lumos Diagnostics, positioning it for growth.
Ada Torres
Ada Torres
29 Aug 2025
The Star Entertainment Group reported a $471.5 million net loss for FY25, marking a 72% improvement from the prior year but underscored by ongoing regulatory challenges and a complex joint venture exit.
Victor Sage
Victor Sage
29 Aug 2025
AF Legal Group has reported a record-breaking FY25 with revenue up 27% to $27.6 million and a 77% jump in normalised profit before tax. The firm’s strategic acquisitions and operational improvements set a positive tone for FY26 growth.
Victor Sage
Victor Sage
29 Aug 2025
Island Pharmaceuticals reported a $3.92 million loss for FY2025 despite an 86% increase in income, with no dividends declared.
Ada Torres
Ada Torres
29 Aug 2025
Bhagwan Marine Limited has delivered a strong first year as an ASX-listed company with record net revenue and EBITDA growth, alongside its inaugural dividend declaration. The company is advancing growth in offshore energy, subsea, ports, and defence sectors while investing in innovation and fleet expansion.
Victor Sage
Victor Sage
29 Aug 2025
BDO Audit has completed its review of HeraMED Limited’s half-year financial report for June 2025, confirming compliance with accounting standards but highlighting significant uncertainty over the company’s ability to continue as a going concern.
Ada Torres
Ada Torres
28 Aug 2025
333D Ltd has reported a remarkable financial turnaround in FY2025, posting a 426% revenue increase and its first profit after tax, driven by its digital asset management strategy.
Sophie Babbage
Sophie Babbage
28 Aug 2025
Percheron Therapeutics posted a 25% increase in net loss for FY2025 amid termination of its Duchenne Muscular Dystrophy programs. The company pivots strategically to oncology with the in-licensing of HMBD-002, a monoclonal antibody targeting VISTA, aiming to initiate Phase II trials in 2026.
Ada Torres
Ada Torres
28 Aug 2025
Mastermyne Group has received a Letter of Intent to extend its underground mining contracts with Anglo American Steelmaking Coal, potentially adding $31 million in revenue through April 2026.
Maxwell Dee
Maxwell Dee
28 Aug 2025
Generation Development Group Limited reported a remarkable 555% increase in net profit for the 2025 financial year, alongside a strategic acquisition that brings Lonsec fully under its control.
Claire Turing
Claire Turing
28 Aug 2025
Qoria Limited reported a robust FY2025 with 25% growth in annual recurring revenue and a 684% jump in EBITDA, underscoring its expanding leadership in global K12 safety and wellbeing platforms.
Sophie Babbage
Sophie Babbage
28 Aug 2025
Smartgroup Corporation Ltd reported a solid first half for 2025 with revenue up 7% and net profit rising 11%, powered by strong novated leasing growth amid shifting electric vehicle policies.
Claire Turing
Claire Turing
28 Aug 2025